State Street Corporation 13D and 13G filings for Fate Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-22 1:46 pm Sale |
2023-12-31 | 13G | Fate Therapeutics, Inc. FATE |
STATE STREET CORP STT |
1,861,919 1.890% |
-410,006 (-18.05%) |
Filing |
| 2023-10-10 11:16 am Sale |
2023-09-30 | 13G | Fate Therapeutics, Inc. FATE |
STATE STREET CORP STT |
2,271,925 2.310% |
-11,717,507 (-83.76%) |
Filing |
| 2023-05-10 09:16 am Purchase |
2023-04-30 | 13G | Fate Therapeutics, Inc. FATE |
STATE STREET CORP STT |
13,989,432 14.240% |
8,053,973 (+135.69%) |
Filing |
| 2023-02-03 09:54 am Purchase |
2022-12-31 | 13G | Fate Therapeutics, Inc. FATE |
STATE STREET CORP STT |
5,935,459 6.110% |
5,935,459 (New Position) |
Filing |